Collin M. Blakely

Also affiliated with University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 31 papers. Top paper: “The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance”.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8

N/A

1.9DataRank · unranked

88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer

Journal of Clinical Investigation(2022)10.1172/jci145099

N/A

1.8DataRank · unranked

59 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Yu‐Ting Chou +23 more

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

Nature Communications(2024)10.1038/s41467-024-47423-0

N/A

1.7DataRank · unranked

93 citations

Yu‐Ting Chou, Lauren Čech, Celia Fernández-Méndez, Johnny Yu, Victor Olivas +30 more

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

Journal of Clinical Oncology(2024)10.1200/jco.24.00071

N/A

1.4DataRank · unranked

60 citations

Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski +19 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0.769DataRank · unranked

168 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

Science Translational Medicine(2022)10.1126/scitranslmed.abc7480

N/A

0.581DataRank · unranked

47 citations

Min Lu, Hazel X. Ang, Ryan S. Soderquist, Christine E. Eyler, Haley M. Hutchinson +12 more

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.18.423280

N/A

0.449DataRank · unranked

19 citations

Deborah R. Caswell, Natalie I. Vokes, Emily K. Law, Wei Wu, William Hill +43 more

A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.23.465573

N/A

0.442DataRank · unranked

18 citations

Celia Fernández-Méndez, Lauren Čech, Johnny Yu, Ismail M. Meraz, Victor Olivas +28 more

Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.06.007

N/A

0.354DataRank · unranked

9 citations

Shigeki Nanjo, Shinji Takeuchi, Turja Chakrabarti, Tyiesha Brown, Sharon Wesley Dev Sahadevan +11 more

Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer

The Oncologist(2024)10.1093/oncolo/oyae349

N/A

0.292DataRank · unranked

6 citations

W. John Boscardin, Louise C. Walter, Alexander K. Smith, Harvey Jay Cohen, Smith Giri +19 more

Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e20540

N/A

0.269DataRank · unranked

5 citations

Rahulsimham Vegesna, Saugato Rahman Dhruba, Wei Wu, D. Lucas Kerr, Oleg V. Stroganov +9 more

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Journal of Visualized Experiments(2021)10.3791/63039-v

N/A

0.220DataRank · unranked

2 citations

Collin M. Blakely, Franziska Haderk, Trever G. Bivona, Dora Barbosa Rabago

Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.11.475728

N/A

0.208DataRank · unranked

3 citations

Rahulsimham Vegesna, Saugato Rahman Dhruba, Wei Wu, D. Lucas Kerr, Oleg V. Stroganov +9 more

Supplementary Figure from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.22541643

N/A

0.128DataRank · unranked

1 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.26.356352

N/A

0.104DataRank · unranked

1 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Siraj M. Ali +14 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541652.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541646.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7011

N/A

0DataRank · unranked

10 citations

Meera Vimala Ragavan, Cheng Chen, Anika Kumar, Stacy W. Gray, Collin M. Blakely +2 more

Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12040

N/A

0DataRank · unranked

0 citations

Louise C. Walter, Alexander K. Smith, Ying Shi, W. John Boscardin, Harvey Jay Cohen +15 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.22541649

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541649.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.c.6549711

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Targeting MEK in non-small cell lung cancer

Current Problems in Cancer(2024)10.1016/j.currproblcancer.2024.101065

N/A

0DataRank · unranked

13 citations

Collin M. Blakely, Jonathan W. Riess, Matthew S. Lara

CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.12.584638

N/A

0DataRank · unranked

3 citations

Philippe Gui, Wei Wu, D. Lucas Kerr, Lisa Tan, Dora Barbosa +10 more

Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.c.6549711.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Targeted DNA sequencing analysis to reveal genetic diversity and androgen-receptor alteration in advanced EGFR mutant lung adenocarcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9526

N/A

0DataRank · unranked

0 citations

Ross A. Okimoto, Collin M. Blakely, James S. Fraser, Trever G. Bivona, Wei Wu

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Journal of Visualized Experiments(2021)10.3791/63039

N/A

0DataRank · unranked

7 citations

Collin M. Blakely, Franziska Haderk, Trever G. Bivona, Dora Barbosa Rabago

Supplementary Figure from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Figshare(2023)10.1158/2159-8290.22541643.v1

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

(2023)10.1158/2159-8290.22541646

N/A

0DataRank · unranked

0 citations

Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster Flayshman +34 more

Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors

Research Square(2022)10.21203/rs.3.rs-1641376/v1

N/A

0DataRank · unranked

0 citations

Sanju Sinha, Rahulsimham Vegesna, Ashwin V. Kammula, Saugato Rahman Dhruba, Wei Wu +14 more